The Board proposes the rule amendment to update the certification requirements for a technologist with a specialty in either Microbiology, Serology/Immunology, Clinical Chemistry, Hematology, Immunohematology, Molecular Pathology, Blood Banking (...

 

DEPARTMENT OF HEALTH
Board of Clinical Laboratory Personnel

RULE NO.: RULE TITLE:
64B3-5.003: Technologist
PURPOSE AND EFFECT: The Board proposes the rule amendment to update the certification requirements for a technologist with a specialty in either Microbiology, Serology/Immunology, Clinical Chemistry, Hematology, Immunohematology, Molecular Pathology, Blood Banking (Donor Processing) and to update the education, training/experience and certification for a technologist with a specialty in histology.
SUMMARY: Certification requirements for a technologist with a specialty in either Microbiology, Serology/Immunology, Clinical Chemistry, Hematology, Immunohematology, Molecular Pathology, Blood Banking (Donor Processing) will be updated. Education, training/experience and certification for a technologist with a specialty in histology will be updated.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:
The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the agency.
The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
RULEMAKING AUTHORITY: 483.805(4), 483.811(2), 483.823 FS.
LAW IMPLEMENTED: 381.0034(3), 483.800, 483.809, 483.811(2), 483.815, 483.823 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Bruce Deterding, Executive Director, Board of Clinical Laboratory Personnel, 4052 Bald Cypress Way, Bin # C07, Tallahassee, Florida 32399-3257

THE FULL TEXT OF THE PROPOSED RULE IS:

64B3-5.003 Technologist.

(1) through (2) No change.

(3) In addition, at least one of the following requirements must be met for specific areas of licensure. In some cases there are multiple options for meeting the requirement.

(a) Microbiology, Serology/Immunology, Clinical Chemistry, Hematology, Immunohematology, Molecular Pathology.

Education	Option	Training/Experience	Certification
Bachelors Degree (or higher) in Clinical Laboratory, Chemical, or Biological Science	1	Clinical laboratory training program, or 3 years experience with a minimum of 6 months in each specialty for which licensure is sought	MLS MT(ASCP), MT(AMT), MT(AAB) NRCC examinations or specialist examinations in single discipline for licensure in that specialty area
90 semester hours college credit	2	Clinical laboratory training program	MLS MT(ASCP), MT(AMT), MT(AAB), or specialist examinations in single discpline for licensure in that specialty area
Associate Degree in Clinical/Medical Laboratory Technology	3	as required by certifying body	MT(AAB) examinations, including specialist examinations, in single disciplines for licensure in that specialty area
Associate Degree	4a	Successfully completed a Department of Defense clinical laboratory training program	MT(AAB) examinations, including specialist examinations, in single disciplines for licensure in that specialty area
	4b	5 years of pertinent clinical laboratory experience with one year of experience in each specialty area for which licensure is sought	MT(AAB) examinations, including specialist examinations, in single disciplines for licensure in that specialty area

(b) Blood Banking

(Donor Processing)

Education	Option	Training/Experience	Certification
Bachelors Degree (or higher) In Medical Technology	1	as required by certifying body	  MLS MT(ASCP),   BB(ASCP),   SBB(ASCP),   MT(AAB),   MT(AMT)
Bachelors Degree (or higher) in Clinical Laboratory, Chemical, or Biological Science	1	Medical Technology Training program, or Board approved training program in Blood Banking, or 3 years experience in clinical laboratory experience in the areas of Chemistry, Serology/Immunology, Hematology, and Immunohematology and Blood Banking	 MLS MT(ASCP),  BB(ASCP),  SBB(ASCP),  MT(AAB),  MT(AMT)

(c) through (f) No change.

(g) Histology.

Education	Option	Training/Experience	Certification
Associate Degree (or higher)	1	NAACLS-approved Histotechnology Program	HT(ASCP)
as required by certifying body	2a	as required by certifying body	HTL(ASCP) or HT(ASCP)QIHC
60 semester hours 12 hours chemical/biological science	2b	Board approved training program	HT (ASCP)
as required by certifying body	3a	5 years of pertinent experience, and 48 contact hours of continuing education in immunohistochemistry/advanced histologic techniques	HT(ASCP)
	3b	5 years of pertinent experience, and 48 contact hours of continuing education in immunohistochemistry/advanced histologic techniques, and licensure as a technician in the specialty of histology	Not required

(h) No change.

Rulemaking Authority 483.805(4), 483.811(2), 483.823 FS. Law Implemented 381.0034(3), 483.800, 483.809, 483.811(2), 483.815, 483.823 FS. History–New 12-6-94, Amended 7-12-95, 9-10-95, 12-4-95, Formerly 59O-5.003, Amended 5-26-98, 1-11-99, 7-5-01, 3-24-02, 10-29-02, 8-16-04, 5-15-05, 12-19-05, 5-25-06, 7-9-07, 2-7-08, 6-17-09, 1-30-12,                               .

NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Clinical Laboratory Personnel
NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Clinical Laboratory Personnel
DATE PROPOSED RULE APPROVED BY AGENCY HEAD: September 7, 2012
DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: October 18, 2012